I have metastatic BC. Should I worry about a mild ALP rise?

Question

Hello doctor,

I am a 56-year-old postmenopausal woman with metastatic estrogen-receptor–positive (ER-positive) and human epidermal growth factor receptor 2-negative (HER2-negative) breast cancer involving the bone and liver.

I have been taking Letrozole 2.5 milligrams daily along with Palbociclib 125 mg in treatment cycles for the past six months.

My most recent scans show stable disease, but my alkaline phosphatase (ALP) level is slightly elevated at 156 units per liter.

Is mild ALP elevation common with bone mets (metastases), or should I worry about progression?
How often should I get bone density scans while on these medicines?
Could supplements like calcium and vitamin D help slow bone damage, or are they just for preventing fractures?
Is there a role for weight-bearing exercise at this stage without worsening pain?

Kindly guide.

Answer 1

Hello,

Welcome to icliniq.com.

I completely understand your concern, and it is excellent that you are staying informed about your health.

A mild elevation in alkaline phosphatase (such as your value of 156 units per liter) can occur in the setting of treated, stable bone metastases and does not always indicate progression.

Since alkaline phosphatase is produced by both bone and liver cells, mild fluctuations may reflect normal bone remodeling or healing after treatment rather than disease spread.

Because Letrozole can reduce bone mineral density, it is important to monitor bone health carefully. A baseline dual-energy X-ray absorptiometry (DEXA) scan should be performed at the start of treatment, followed by repeat scans every one to two years unless new symptoms arise or fracture risk increases.

Your oncologist may adjust the timing depending on your situation. Calcium and vitamin D supplementation play an important role in supporting bone health and preventing fractures during treatment. While they cannot reverse existing bone metastases, they help maintain bone strength and may work synergistically with bone-targeted treatments such as Bisphosphonate therapy or Denosumab.

These additional medications may already be part of your oncologist’s long-term management plan.

To help support bone health safely at this stage, consider the following:

Choose gentle weight-bearing exercises such as walking, light resistance training, or yoga.
Avoid high-impact activities and heavy lifting in areas affected by bone metastases to reduce fracture risk.
Coordinate with your oncology and physiotherapy teams to develop a safe, individualized exercise plan.

I hope this information helps you.

Thank you.